Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
86.53
+0.55 (+0.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
262,200
Open
86.33
Bid (Size)
86.00 (2)
Ask (Size)
88.00 (1)
Prev. Close
85.98
Today's Range
85.05 - 86.93
52wk Range
55.02 - 98.40
Shares Outstanding
47,190,970
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
July 24, 2024
Jim Cramer discusses Torm, Trane, Sap and Axsome Therapeutics on CNBC's "Mad Money Lightning Round."
Via
Benzinga
Performance
YTD
+12.29%
+12.29%
1 Month
+8.04%
+8.04%
3 Month
+17.42%
+17.42%
6 Month
-6.37%
-6.37%
1 Year
+9.98%
+9.98%
More News
Read More
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Via
InvestorPlace
Decoding 9 Analyst Evaluations For Axsome Therapeutics
July 18, 2024
Via
Benzinga
Should You Buy This Sinking Stock on the Dip?
June 27, 2024
Via
The Motley Fool
15 Analysts Assess Axsome Therapeutics: What You Need To Know
June 05, 2024
Via
Benzinga
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
July 22, 2024
Via
Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
July 15, 2024
Via
The Motley Fool
Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
July 11, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
Via
InvestorPlace
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
July 04, 2024
Via
InvestorPlace
Why Axsome Therapeutics Stock Is Sinking Today
June 11, 2024
Via
The Motley Fool
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
June 05, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
June 04, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
June 03, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences
May 30, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
May 29, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
May 28, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
May 28, 2024
Via
Benzinga
3 Monster Stocks in the Making You Can Buy Right Now
May 18, 2024
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
May 11, 2024
Via
InvestorPlace
Prediction: These 2 Growth Stocks Could Triple By 2030
May 11, 2024
Via
The Motley Fool
Axsome Therapeutics to Present at Upcoming Investor Conferences
May 08, 2024
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
May 06, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.